There is a 99% chance of new drug approval now, launch in Feb 2025, as oer MD market is 80 B USD which is huge, lot of growth in intrinsic value going forward, WCK4777 is also fast tracked, Wockhardt has three more molecules in QIDP, this might become most valuable company of Pharma sector based on opportunity size. First indian company to launch a drug.
Disclaimer: holding from 600 levels in core portfolio for long long term.
| Subscribe To Our Free Newsletter |
